
Ligand Pharmaceuticals Inc
LGNDHealthcare|Biotechnology|USA
$316.24
-6.50 (-2.01%)
DCF (FCF)
$71.09
Tangible Book
$33.87
Graham Number
$79.73
Earnings Power
$30.25
About
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
Stock Price
+153.0%(1Y)
Pipeline Summary
41 total trials12
Phase 1
24
Phase 2
4
Phase 3
1
Phase 4
Withdrawn: 2Completed: 37Terminated: 2
BioScore
2.8/10
High Risk
Ownership
Recent Insider Trades
Reardon AndrewSELL
2026-07-015,000 shares @ $313.28
Sabba Stephen LSELL
2026-06-162,145 shares @ $254
Haas JasonSELL
2026-06-126,461 shares @ $255.58
Aryeh JasonSELL
2026-06-115,000 shares @ $250
LAMATTINA JOHN LSELL
2026-06-104,591 shares @ $250.88
Recent News
2026-07-09 12:01:25
2026-07-08 16:03:16
2026-06-23 12:50:48
2026-06-23 09:57:55
2026-06-22 12:01:26
Data last updated: Jul 12, 2026, 07:42 PM